Mirae Asset Global Investments
ATNM icon

Mirae Asset Global Investments’s Actinium Pharmaceuticals ATNM Stock Holding History

Mirae Asset Global Investments’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,285
Closed -$72.6K – 2452
2023
Q4 		$72.6K Hold
14,285
– – ﹤0.01% 2502
2023
Q3 		$84.6K Hold
14,285
– – ﹤0.01% 2495
2023
Q2 		$106K Buy
+14,285
New +$122K ﹤0.01% 2496

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mirae Asset Global Investments's ATNM Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Actinium Pharmaceuticals (ATNM) in Q1 2024, closing a stake of 14,285 shares — an estimated $72.6K sold.

Mirae Asset Global Investments first reported a position in ATNM in Q2 2023 and held it in 3 quarters. The position peaked at $106K in Q2 2023. 67 funds tracked by Wall St. Rank hold ATNM as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Actinium Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 14,285 Actinium Pharmaceuticals shares in Q1 2024, an estimated $72.6K.
  • Mirae Asset Global Investments first reported a position in Actinium Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Actinium Pharmaceuticals position peaked at $106K in Q2 2023.
  • 67 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.